Methylprednisolone Completed Phase 1 Trials for Myelodysplastic Syndromes (MDS) / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00376480Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant